X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (683) 683
Publication (43) 43
Book Review (15) 15
Book Chapter (10) 10
Magazine Article (4) 4
Conference Proceeding (2) 2
Data Set (1) 1
Dissertation (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (631) 631
female (345) 345
index medicus (343) 343
male (324) 324
adult (243) 243
middle aged (233) 233
jaw neoplasms - metabolism (214) 214
dentistry, oral surgery & medicine (195) 195
jaw neoplasms - pathology (186) 186
immunohistochemistry (175) 175
aged (173) 173
dentistry (141) 141
pathology (129) 129
cancer (128) 128
ameloblastoma - metabolism (123) 123
oncology (116) 116
adolescent (114) 114
surgery (110) 110
endocrinology & metabolism (109) 109
tumors (108) 108
ameloblastoma - pathology (105) 105
jaw (100) 100
ameloblastoma (97) 97
diphosphonates - adverse effects (96) 96
expression (94) 94
jaw neoplasms - genetics (91) 91
bone density conservation agents - adverse effects (81) 81
child (81) 81
osteonecrosis (75) 75
bones (73) 73
necrosis (73) 73
young adult (70) 70
jaws (69) 69
risk factors (68) 68
analysis (66) 66
osteonecrosis - chemically induced (65) 65
animals (63) 63
bisphosphonates (61) 61
jaw tumor syndrome (61) 61
zoledronic acid (61) 61
aged, 80 and over (59) 59
odontogenic tumors - metabolism (59) 59
risk-factors (55) 55
odontogenic tumors - pathology (54) 54
tumor suppressor proteins - genetics (54) 54
carcinoma (53) 53
medicine & public health (52) 52
jaw diseases - chemically induced (51) 51
retrospective studies (51) 51
diphosphonates - therapeutic use (49) 49
bone neoplasms - drug therapy (47) 47
odontogenic cysts - metabolism (47) 47
osteoporosis (47) 47
parathyroid neoplasms - genetics (47) 47
biomarkers, tumor - metabolism (44) 44
care and treatment (44) 44
mutation (44) 44
mutations (44) 44
cell proliferation (43) 43
bone density conservation agents - therapeutic use (42) 42
metastasis (42) 42
parafibromin (42) 42
hyperparathyroidism - genetics (41) 41
research (41) 41
bone (40) 40
bone neoplasms - secondary (39) 39
diagnosis (39) 39
cysts (38) 38
hyperparathyroidism (38) 38
proteins (38) 38
diagnosis, differential (37) 37
cells (35) 35
immunoenzyme techniques (35) 35
odontogenic cysts - pathology (35) 35
diphosphonates - administration & dosage (34) 34
gene expression (34) 34
parathyroid carcinoma (34) 34
apoptosis (33) 33
mice (33) 33
osteonecrosis of the jaw (33) 33
therapy (33) 33
cell biology (32) 32
genetic aspects (32) 32
prognosis (31) 31
adenoma - genetics (30) 30
familial isolated hyperparathyroidism (30) 30
abridged index medicus (29) 29
ameloblastoma - genetics (29) 29
hrpt2 gene (29) 29
treatment outcome (29) 29
bisphosphonate (28) 28
breast-cancer (28) 28
head (28) 28
health aspects (28) 28
osteoporosis - drug therapy (28) 28
bone density conservation agents - administration & dosage (27) 27
gene expression regulation, neoplastic (27) 27
management (27) 27
neoplasms - drug therapy (27) 27
imidazoles - adverse effects (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (664) 664
Chinese (25) 25
German (9) 9
Russian (6) 6
Japanese (5) 5
Italian (4) 4
French (2) 2
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Oral Pathology & Medicine, ISSN 0904-2512, 04/2015, Volume 44, Issue 4, pp. 284 - 290
Background Pilomatrixoma, craniopharyngioma, and calcifying cystic odontogenic tumor are the main entities presenting ghost cells as an important histological... 
calcifying cystic odontogenic tumor | immunohistochemistry | pilomatrixoma | ghost cells | craniopharyngioma | Immunohistochemistry | Calcifying cystic odontogenic tumor | Craniopharyngioma | Pilomatrixoma | Ghost cells | BETA-CATENIN GENE | KERATINIZATION | PATHOLOGY | PATHWAY | DENTISTRY, ORAL SURGERY & MEDICINE | MUTATIONS | SKIN | EXPRESSION | EPITHELIOMA | CARCINOMA | Hair Diseases - pathology | Odontogenic Cyst, Calcifying - pathology | Humans | Pilomatrixoma - ultrastructure | Glucose Transporter Type 1 - metabolism | fas Receptor - metabolism | Jaw Neoplasms - pathology | Jaw Neoplasms - ultrastructure | Keratins - metabolism | Hair Diseases - metabolism | Odontogenic Cyst, Calcifying - ultrastructure | Odontogenic Tumors - ultrastructure | Skin Neoplasms - pathology | Microscopy, Electron, Scanning | Craniopharyngioma - pathology | Syndecan-1 - metabolism | Craniopharyngioma - ultrastructure | Epithelial Cells - pathology | Pituitary Neoplasms - pathology | Pilomatrixoma - pathology | Jaw Neoplasms - metabolism | Neprilysin - metabolism | Odontogenic Cyst, Calcifying - metabolism | Odontogenic Tumors - pathology | Pituitary Neoplasms - metabolism | beta Catenin - metabolism | Skin Neoplasms - metabolism | Craniopharyngioma - metabolism | Skin Neoplasms - ultrastructure | Pituitary Neoplasms - ultrastructure | Pilomatrixoma - metabolism | Odontogenic Tumors - metabolism | Electron microscopy | Pituitary gland tumors
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e70995
Keratocystic odontogenic tumor (KCOT) arises as part of Gorlin syndrome (GS) or as a sporadic lesion. Gene mutations and loss of heterozygosity (LOH) of the... 
SUPPRESSOR GENE | CLINICAL-MANIFESTATIONS | MULTIDISCIPLINARY SCIENCES | BASAL-CELL CARCINOMA | DEVELOPMENTAL DEFECTS | MICE | GORLIN-SYNDROME | NEVUS SYNDROME | CANCER | MEDULLOBLASTOMA | HUMAN HOMOLOG | Immunohistochemistry | Humans | Middle Aged | Zinc Finger Protein Gli2 | Hedgehog Proteins - metabolism | Male | Patched-2 Receptor | Loss of Heterozygosity | Jaw Neoplasms - pathology | Young Adult | Hedgehog Proteins - genetics | Kruppel-Like Transcription Factors - metabolism | Aged, 80 and over | Adult | Female | Patched Receptors | Nuclear Proteins - genetics | Child | Odontogenic Cysts - pathology | Repressor Proteins - metabolism | Receptors, Cell Surface - metabolism | Repressor Proteins - genetics | Genotype | Nuclear Proteins - metabolism | Signal Transduction - genetics | Jaw Neoplasms - metabolism | Odontogenic Cysts - genetics | Odontogenic Tumors - pathology | Odontogenic Tumors - genetics | Adolescent | Aged | Mutation | Odontogenic Tumors - metabolism | Jaw Neoplasms - genetics | Kruppel-Like Transcription Factors - genetics | Odontogenic Cysts - metabolism | Patched-1 Receptor | Receptors, Cell Surface - genetics | Medical research | Gene mutations | Analysis | Genes | Medicine, Experimental | Genetic aspects | Tumors | Health sciences | Restitution | Pathogenesis | Genomes | Bone diseases | Tissues | Subgroups | Maxillofacial surgery | Odontogenic tumors | Gorlin syndrome | Rodents | Surgery | Tumorigenesis | Localization | Gene expression | Patients | Heterozygosity | Pathology | Signaling | Cysts | Insects | Hedgehog protein | Oral hygiene | Medical prognosis | Loss of heterozygosity | Budding | Cancer
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 01/2019, Volume 34, Issue 1, pp. 22 - 37
ABSTRACT We review advancing and overlapping stages for our understanding of the expressions of six hyperparathyroid (HPT) syndromes: multiple endocrine... 
RET | CASR | CDKN1B | GNA11 | AP2S1 | CDC73 | GCM2< | MEN1 | KWD> | MEDULLARY-THYROID-CARCINOMA | EXTRACELLULAR CA2+-SENSING RECEPTOR | NEONATAL SEVERE HYPERPARATHYROIDISM | BENIGN HYPERCALCEMIA | DEPENDENT KINASE INHIBITOR | CALCIUM-SENSING RECEPTOR | GERM-LINE MUTATIONS | ENDOCRINOLOGY & METABOLISM | MULTIPLE ENDOCRINE NEOPLASIA | TUMOR-SUPPRESSOR PROTEIN | FAMILIAL HYPOCALCIURIC HYPERCALCEMIA | Multiple Endocrine Neoplasia Type 2a - history | History, 21st Century | History, 20th Century | Humans | Multiple Endocrine Neoplasia Type 1 - classification | Hyperparathyroidism - classification | Multiple Endocrine Neoplasia Type 1 - genetics | Neoplasm Proteins - metabolism | Parathyroid Neoplasms - genetics | Parathyroid Neoplasms - metabolism | Multiple Endocrine Neoplasia Type 2a - classification | Syndrome | Parathyroid Neoplasms - classification | Hyperparathyroidism - metabolism | Multiple Endocrine Neoplasia Type 1 - metabolism | Hyperparathyroidism - genetics | Multiple Endocrine Neoplasia Type 1 - history | Hyperparathyroidism - history | Multiple Endocrine Neoplasia Type 2a - metabolism | Multiple Endocrine Neoplasia Type 2a - genetics | Neoplasm Proteins - genetics | Parathyroid Neoplasms - history | Neonates | Jaw | Genes | Insulin | Hypercalcemia | Calcium (blood) | Vitamin D | Parathyroid hormone | Prolactin | Multiple endocrine neoplasia | Calcitonin | Gastrin | Skin diseases | Parathyroid | Calcium-sensing receptors | Hyperparathyroidism | GCM2
Journal Article
Clinical & Experimental Metastasis, ISSN 0262-0898, 4/2013, Volume 30, Issue 4, pp. 529 - 540
Journal Article
The Journal of Pathology, ISSN 0022-3417, 04/2014, Volume 232, Issue 5, pp. 492 - 498
Ameloblastoma is a benign but locally infiltrative odontogenic neoplasm. Although ameloblastomas rarely metastasise, recurrences together with radical surgery... 
targeted therapy | odontogenic tumour | BRAF | oncogenic mutation | EGFR | ameloblastoma | GEFITINIB | TRANSGENIC MOUSE | PATHOLOGY | METASTATIC COLORECTAL-CANCER | PANITUMUMAB | LUNG-CANCER | ONCOLOGY | FACTOR RECEPTOR EXPRESSION | KRAS | EGF RECEPTOR | CELL-LINE | ERLOTINIB | Ameloblastoma - drug therapy | Receptor, Epidermal Growth Factor - genetics | Jaw Neoplasms - drug therapy | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Ameloblastoma - enzymology | Molecular Targeted Therapy | Jaw Neoplasms - pathology | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Receptor, Epidermal Growth Factor - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Ameloblastoma - pathology | Antineoplastic Agents - pharmacology | Jaw Neoplasms - enzymology | Proto-Oncogene Proteins B-raf - metabolism | Cell Survival - drug effects | Genetic Predisposition to Disease | Gene Frequency | Ameloblastoma - genetics | Phenotype | Signal Transduction - drug effects | Proto-Oncogene Proteins B-raf - genetics | Adolescent | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Mutation | Receptor, ErbB-4 | Jaw Neoplasms - genetics | Immunohistochemistry | Genetic aspects | Gene mutations | Analysis | Pathogenesis | Original Papers
Journal Article
Endocrine Journal, ISSN 0918-8959, 2019, Volume 66, Issue 4, pp. 319 - 327
Journal Article